Sign In
Buy ARAY
$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Why Shares of Accuray Jumped Thursday
03:17pm, Thursday, 02'nd Feb 2023
The radiation-oncology machine company saw shares rise after it released an earnings report.
Accuray Achieves Record Product Revenue, But There's Much Work Still To Be Done
01:48pm, Thursday, 02'nd Feb 2023
Accuray's revenue did fall year-over-year as reported, but the company beat expectations and product revenue reached a new all-time high with 8% year-over-year constant-currency growth. Orders grew se
Accuray Incorporated (ARAY) Q2 2023 Earnings Call Transcript
10:59pm, Wednesday, 01'st Feb 2023
Accuray Incorporated (NASDAQ:ARAY ) Q2 2023 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Jesse Chew - Senior Vice President, General Counsel & Corporate Secretary Suzanne
Accuray (ARAY) Reports Q2 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 01'st Feb 2023
Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 7.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Bear of the Day: Fresenius Medical (FMS)
12:00pm, Friday, 11'th Nov 2022 Zacks Investment Research
Profit estimates are moving in the wrong direction.
Accuray's (ARAY) Q1 Earnings and Revenues Lag Estimates
04:51pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Despite solid product demand, Accuray (ARAY) reports an overall soft Q1 performance.
Accuray's (ARAY) Q1 Earnings and Revenues Lag Estimates
02:18pm, Thursday, 03'rd Nov 2022
Despite solid product demand, Accuray (ARAY) reports an overall soft Q1 performance.
Accuray (ARAY) Reports Q1 Loss, Misses Revenue Estimates
10:45pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Accuray (ARAY) delivered earnings and revenue surprises of -500% and 8.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Accuray Incorporated (ARAY) Q1 2023 Earnings Call Transcript
09:18pm, Wednesday, 02'nd Nov 2022
Accuray Incorporated (NASDAQ:ARAY ) Q1 2023 Results Conference Call November 2, 2022 4:30 AM ET Company Participants Ken Mobeck - Vice President of Finance and Investor Relations Suzanne Winter - Chie
Accuray (ARAY) Reports Q1 Loss, Misses Revenue Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Accuray (ARAY) delivered earnings and revenue surprises of -500% and 8.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
03:55pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Ecolab (ECL) Q3 Earnings & Revenues Miss Mark, Margins Down
03:53pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Ecolab's (ECL) robust performance across all its segments drives its Q3 sales, despite business challenges.
DexCom (DXCM) Q3 Earnings Beat Estimates, Guidance Revised
04:58pm, Friday, 28'th Oct 2022 Zacks Investment Research
DexCom's (DXCM) third-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Baxter (BAX) Q3 Earnings Meet Estimates, Hilrom Adds $735 M
04:32pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Baxter's (BAX) third-quarter results reflect the robust performance of the Medication Delivery business unit and Hilrom's businesses.
Integra's (IART) Q3 Earnings Top, Gross Margin Declines
03:51pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Integra (IART) notices recovery in procedure volumes leading to solid growth across most of its product portfolio in Q3.
